$AIMD
Ainos, Inc. Stock $aimd

$aimd Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-Q Financial Statement

#000149315224043832 Filed on November 06, 2024

Income Statement

Concept	2024 Q4	2024 Q3	2023 Q4
Revenue			$19.90K
YoY Change			-98.08%
Cost Of Revenue		$547.00	$131.3K
YoY Change		-99.38%	-77.29%
Gross Profit		-$547.00	-$111.4K
YoY Change		-99.14%	-124.23%
Gross Profit Margin			-559.85%
Selling, General & Admin		$1.016M	$3.353M
YoY Change		12.61%	325.72%
% of Gross Profit
Research & Development		$2.022M	$2.237M
YoY Change		18.24%	24.36%
% of Gross Profit
Depreciation & Amortization		$1.212M	$1.221M
YoY Change		-1.49%	-0.35%
% of Gross Profit
Operating Expenses		$3.038M	$5.590M
YoY Change		16.3%	116.12%
Operating Profit		-$3.039M	-$5.701M
YoY Change		13.56%	168.09%
Interest Expense		-$264.6K	-$50.34K
YoY Change		-697.83%	512.41%
% of Operating Profit
Other Income/Expense, Net		-$660.8K	-$266.5K
YoY Change		120.12%	-7112.37%
Pretax Income		-$3.699M	-$5.924M
YoY Change		24.31%	177.98%
Income Tax			$800.00
% Of Pretax Income
Net Earnings		-$3.699M	-$5.925M
YoY Change		24.31%	178.01%
Net Earnings / Revenue			-29771.36%
Basic Earnings Per Share		-$0.33
Diluted Earnings Per Share		-$0.33	-$1.37
COMMON SHARES
Basic Shares Outstanding	13.84M shares	7.663M shares	20.29M shares
Diluted Shares Outstanding		11.28M shares

Balance Sheet

Concept	2024 Q3	2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$5.157M	$1.886M
YoY Change	117.58%	1.74%
Cash & Equivalents	$5.157M	$1.886M
Short-Term Investments
Other Short-Term Assets	$331.9K	$419.5K
YoY Change	-26.24%	114.27%
Inventory	$160.7K	$167.6K
Prepaid Expenses
Receivables		$455.00
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$5.649M	$2.473M
YoY Change	85.82%	-13.1%
LONG-TERM ASSETS
Property, Plant & Equipment	$649.1K	$876.6K
YoY Change	-44.12%	-36.28%
Goodwill
YoY Change
Intangibles	$24.89M	$28.28M
YoY Change	-15.41%	-13.79%
Long-Term Investments
YoY Change
Other Assets	$183.2K	$208.8K
YoY Change	-22.1%	158.83%
Total Long-Term Assets	$25.72M	$29.37M
YoY Change	-16.54%	-14.29%
TOTAL ASSETS
Total Short-Term Assets	$5.649M	$2.473M
Total Long-Term Assets	$25.72M	$29.37M
Total Assets	$31.37M	$31.84M
YoY Change	-7.35%	-14.19%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses	$750.6K	$1.182M
YoY Change	12.03%	-2.48%
Deferred Revenue	$110.1K	$112.6K
YoY Change
Short-Term Debt	$270.0K	$42.00K
YoY Change		-95.25%
Long-Term Debt Due	$3.000M	$0.00
YoY Change	7400.0%	-100.0%
Total Short-Term Liabilities	$4.131M	$1.337M
YoY Change	404.07%	-45.94%
LONG-TERM LIABILITIES
Long-Term Debt	$9.000M	$5.922M
YoY Change	70.78%
Other Long-Term Liabilities	$216.8K	$135.8K
YoY Change	142.64%	1576.9%
Total Long-Term Liabilities	$216.8K	$135.8K
YoY Change	142.64%	1576.9%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.131M	$1.337M
Total Long-Term Liabilities	$216.8K	$135.8K
Total Liabilities	$13.35M	$7.394M
YoY Change	116.02%	198.03%
SHAREHOLDERS EQUITY
Retained Earnings	-$48.10M	-$37.89M
YoY Change	50.48%	57.1%
Common Stock	$138.1K	$46.78K
YoY Change	-31.93%	-76.62%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$18.02M	$24.45M
YoY Change
Total Liabilities & Shareholders Equity	$31.37M	$31.84M
YoY Change	-7.35%	-14.19%

Cashflow Statement

Concept	2024 Q3	2023 Q4
OPERATING ACTIVITIES
Net Income	-$3.699M	-$5.925M
YoY Change	24.31%	178.01%
Depreciation, Depletion And Amortization	$1.212M	$1.221M
YoY Change	-1.49%	-0.35%
Cash From Operating Activities	-$1.475M	-$1.375M
YoY Change	99.34%	123.36%
INVESTING ACTIVITIES
Capital Expenditures	$10.14K	-$17.02K
YoY Change	-74.65%	-52.68%
Acquisitions
YoY Change
Other Investing Activities	-$8.630K	$1.460K
YoY Change	-13.7%	-237.74%
Cash From Investing Activities	-$18.79K	$18.47K
YoY Change	-62.42%	-47.08%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-1.482M	903.7K
YoY Change	-180.97%	-19533.76%
NET CHANGE
Cash From Operating Activities	-1.475M	-1.375M
Cash From Investing Activities	-18.79K	18.47K
Cash From Financing Activities	-1.482M	903.7K
Net Change In Cash	-2.976M	-452.5K
YoY Change	-386.12%	-22.67%
FREE CASH FLOW
Cash From Operating Activities	-$1.475M	-$1.375M
Capital Expenditures	$10.14K	-$17.02K
Free Cash Flow	-$1.485M	-$1.358M
YoY Change	90.42%	134.29%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001014763
CY2023Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent		usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	455	usd
CY2024Q3	us-gaap	Inventory Net InventoryNet	160701	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	167593	usd
CY2024Q3	us-gaap	Other Assets Current OtherAssetsCurrent	331898	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	419521	usd
CY2024Q3	us-gaap	Assets Current AssetsCurrent	5649205	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	2473197	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1885628	usd
CY2024Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	24888249	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	28283208	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	876572	usd
CY2024Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	183229	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	208827	usd
CY2024Q3	us-gaap	Assets Assets	31369746	usd
CY2023Q4	us-gaap	Assets Assets	31841804	usd
CY2024Q3	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	3000000	usd
CY2023Q4	us-gaap	Convertible Debt Fair Value Disclosures ConvertibleDebtFairValueDisclosures	2651556	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2024Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2024Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-41461
	dei	Entity Registrant Name EntityRegistrantName	AINOS, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	TX
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	75-1974352
	dei	Entity Address Address Line1 EntityAddressAddressLine1	8880 Rio San Diego Drive
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Ste. 800
	dei	Entity Address City Or Town EntityAddressCityOrTown	San Diego
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	92108
	dei	City Area Code CityAreaCode	(858)
	dei	Local Phone Number LocalPhoneNumber	869-2986
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	13838826	shares
	dei	Entity Listing Par Value Per Share EntityListingParValuePerShare	0.01
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5156606	usd
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4677787	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4677787	shares
CY2024Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent		usd
CY2024Q3	us-gaap	Convertible Debt Fair Value Disclosures ConvertibleDebtFairValueDisclosures		usd
CY2024Q3	AIMD	Other Notes Payable Related Party Noncurrent OtherNotesPayableRelatedPartyNoncurrent		usd
CY2024Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q3	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2024Q3	us-gaap	Revenues Revenues		usd
CY2023Q3	AIMD	Fair Value Change Of Senior Secured Convertible Note FairValueChangeOfSeniorSecuredConvertibleNote		usd
	AIMD	Fair Value Change Of Senior Secured Convertible Note FairValueChangeOfSeniorSecuredConvertibleNote		usd
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2024Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
CY2024Q3	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther		usd
	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues		usd
	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther		usd
	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
	us-gaap	Inventory Write Down InventoryWriteDown		usd
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives		usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
	AIMD	Repayment Of Senior Secured Convertible Notes Payable RepaymentOfSeniorSecuredConvertibleNotesPayable		usd
	AIMD	Repayment Of Convertible Notes Payable Related Party RepaymentOfConvertibleNotesPayableRelatedParty		usd
	AIMD	Conversion Of Convertible Notes Payable To Common Stock And Accrued Interest Waived By Convertible Notes Holders ConversionOfConvertibleNotesPayableToCommonStockAndAccruedInterestWaivedByConvertibleNotesHolders		usd
	AIMD	Conversion Of Senior Secured Convertible Notes To Common Stock ConversionOfSeniorSecuredConvertibleNotesToCommonStock		usd
	AIMD	Issuance Of Common Stocks In Exchange Of Vehicle IssuanceOfCommonStocksInExchangeOfVehicle		usd
	AIMD	Account Payable To Purchase Equipment AccountPayableToPurchaseEquipment		usd
CY2024Q3	AIMD	Inventory Writedowns Net Realizable Values InventoryWritedownsNetRealizableValues		usd
	AIMD	Inventory Writedowns Net Realizable Values InventoryWritedownsNetRealizableValues		usd
CY2024Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability		usd
CY2024Q3	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense		usd
	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	649063	usd
CY2024Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	110142	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	112555	usd
CY2024Q3	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	270000	usd
CY2023Q4	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	42000	usd
CY2024Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	750629	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1182283	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	4130771	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1336838	usd
CY2024Q3	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	9000000	usd
CY2023Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	3000000	usd
CY2023Q4	AIMD	Other Notes Payable Related Party Noncurrent OtherNotesPayableRelatedPartyNoncurrent	270000	usd
CY2024Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	216760	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	135829	usd
CY2024Q3	us-gaap	Liabilities Liabilities	13347531	usd
CY2023Q4	us-gaap	Liabilities Liabilities	7394223	usd
CY2024Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	13813434	shares
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	13813434	shares
CY2024Q3	us-gaap	Common Stock Value CommonStockValue	138134	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	46778	usd
CY2024Q3	AIMD	Shares Obligated To Issue SharesObligatedToIssue	900	shares
CY2023Q4	AIMD	Shares Obligated To Issue SharesObligatedToIssue	162337	shares
CY2024Q3	AIMD	Common Stock Issuable CommonStockIssuable	9	usd
CY2023Q4	AIMD	Common Stock Issuable CommonStockIssuable	1623	usd
CY2024Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	66223783	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	62555808	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-48095304	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-37886155	usd
CY2024Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-244407	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-270473	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	18022215	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	24447581	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	31369746	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	31841804	usd
CY2023Q3	us-gaap	Revenues Revenues	24489	usd
	us-gaap	Revenues Revenues	20729	usd
	us-gaap	Revenues Revenues	102208	usd
CY2024Q3	us-gaap	Cost Of Revenue CostOfRevenue	547	usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue	87873	usd
	us-gaap	Cost Of Revenue CostOfRevenue	52674	usd
	us-gaap	Cost Of Revenue CostOfRevenue	244538	usd
CY2024Q3	us-gaap	Gross Profit GrossProfit	-547	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	-63384	usd
	us-gaap	Gross Profit GrossProfit	-31945	usd
	us-gaap	Gross Profit GrossProfit	-142330	usd
CY2024Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2022244	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1710265	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6085648	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5080335	usd
CY2024Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1015758	usd
CY2023Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	902017	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3090056	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2282631	usd
CY2024Q3	us-gaap	Operating Expenses OperatingExpenses	3038002	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	2612282	usd
	us-gaap	Operating Expenses OperatingExpenses	9175704	usd
	us-gaap	Operating Expenses OperatingExpenses	7362966	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-3038549	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2675666	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-9207649	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-7505296	usd
CY2024Q3	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	264642	usd
CY2023Q3	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	44267	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	432097	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	93852	usd
CY2024Q3	AIMD	Issurance Cost Of Senior Secured Convertible Note Measured At Fair Value IssuranceCostOfSeniorSecuredConvertibleNoteMeasuredAtFairValue	-169344	usd
CY2023Q3	AIMD	Issurance Cost Of Senior Secured Convertible Note Measured At Fair Value IssuranceCostOfSeniorSecuredConvertibleNoteMeasuredAtFairValue	-260967	usd
	AIMD	Issurance Cost Of Senior Secured Convertible Note Measured At Fair Value IssuranceCostOfSeniorSecuredConvertibleNoteMeasuredAtFairValue	-308336	usd
	AIMD	Issurance Cost Of Senior Secured Convertible Note Measured At Fair Value IssuranceCostOfSeniorSecuredConvertibleNoteMeasuredAtFairValue	-260967	usd
CY2024Q3	AIMD	Fair Value Change Of Senior Secured Convertible Note FairValueChangeOfSeniorSecuredConvertibleNote	-177212	usd
	AIMD	Fair Value Change Of Senior Secured Convertible Note FairValueChangeOfSeniorSecuredConvertibleNote	-275624	usd
CY2024Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-49570	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	5054	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	14557	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	14067	usd
CY2024Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-660768	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-300180	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1001500	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-340752	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3699317	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2975846	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-10209149	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-7846048	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-3699317	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-2975846	usd
	us-gaap	Net Income Loss NetIncomeLoss	-10209149	usd
	us-gaap	Net Income Loss NetIncomeLoss	-7846048	usd
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.33
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.33
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.73
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.73
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.30
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.30
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.95
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.95
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11279220	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11279220	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4058413	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4058413	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7868997	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7868997	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4026756	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4026756	shares
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-3699317	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-2975846	usd
	us-gaap	Net Income Loss NetIncomeLoss	-10209149	usd
	us-gaap	Net Income Loss NetIncomeLoss	-7846048	usd
CY2024Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest	-135981	usd
CY2023Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest	78833	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest	-26066	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest	122639	usd
CY2024Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3563336	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3054679	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-10183083	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-7968687	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	20712276	usd
CY2024Q3	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	402484	usd
CY2024Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	470791	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-3699317	usd
CY2024Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	135981	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	18022215	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	30395337	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	15467	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	324842	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-2975846	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	-78833	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	27680967	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	24447581	usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	2441691	usd
	AIMD	Adjustments To Additional Paid In Capital Related Party Used Computer Equipment Amount AdjustmentsToAdditionalPaidInCapitalRelatedPartyUsedComputerEquipmentAmount	-4428	usd
	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	1586	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1318868	usd
	us-gaap	Net Income Loss NetIncomeLoss	-10209149	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	26066	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	18022215	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	34628006	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	34628006	usd
	AIMD	Stock Issued During Period Value Exchange Stock In Of Vehicle Amount StockIssuedDuringPeriodValueExchangeStockInOfVehicleAmount	48559	usd
	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	274789	usd
	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	15467	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	682833	usd
	us-gaap	Net Income Loss NetIncomeLoss	-7846048	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	-122639	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	27680967	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	27680967	usd
	us-gaap	Net Income Loss NetIncomeLoss	-10209149	usd
	us-gaap	Net Income Loss NetIncomeLoss	-7846048	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3610387	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3653746	usd
	us-gaap	Inventory Write Down InventoryWriteDown	120931	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1318868	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	682833	usd
	AIMD	Issurance Cost Of Senior Secured Convertible Note Measured At Fair Value IssuranceCostOfSeniorSecuredConvertibleNoteMeasuredAtFairValue	-308336	usd
	AIMD	Issurance Cost Of Senior Secured Convertible Note Measured At Fair Value IssuranceCostOfSeniorSecuredConvertibleNoteMeasuredAtFairValue	-260967	usd
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-275624	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-455	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-201384	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-6892	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-6812	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-87623	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	757	usd
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-343072	usd
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-401622	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4944036	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3321754	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	20423	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	107867	usd
	AIMD	Increase In Refundable Deposits And Other Assets IncreaseInRefundableDepositsAndOtherAssets	118154	usd
	AIMD	Increase In Refundable Deposits And Other Assets IncreaseInRefundableDepositsAndOtherAssets	9661	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-138577	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-117528	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	1000000	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	9000000	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	2000000	usd
	us-gaap	Proceeds From Secured Notes Payable ProceedsFromSecuredNotesPayable	875000	usd
	us-gaap	Proceeds From Secured Notes Payable ProceedsFromSecuredNotesPayable	2000000	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	42000	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	572000	usd
	AIMD	Repayment Of Senior Secured Convertible Notes Payable RepaymentOfSeniorSecuredConvertibleNotesPayable	1439754	usd
	AIMD	Repayment Of Convertible Notes Payable Related Party RepaymentOfConvertibleNotesPayableRelatedParty	114026	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	97500	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	290000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	8295746	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4023974	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	57845	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-67091	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	3270978	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	517601	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1885628	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1853362	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5156606	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2370963	usd
	us-gaap	Interest Paid Net InterestPaidNet	3932	usd
	us-gaap	Interest Paid Net InterestPaidNet	16897	usd
	AIMD	Conversion Of Convertible Notes Payable To Common Stock And Accrued Interest Waived By Convertible Notes Holders ConversionOfConvertibleNotesPayableToCommonStockAndAccruedInterestWaivedByConvertibleNotesHolders	274789	usd
	AIMD	Conversion Of Senior Secured Convertible Notes To Common Stock ConversionOfSeniorSecuredConvertibleNotesToCommonStock	2441691	usd
	AIMD	Issuance Of Common Stocks In Exchange Of Vehicle IssuanceOfCommonStocksInExchangeOfVehicle	48559	usd
	AIMD	Account Payable To Purchase Equipment AccountPayableToPurchaseEquipment	107867	usd
CY2023Q4	us-gaap	Share Price SharePrice	1.00
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84B_eus-gaap--UseOfEstimates_zbywwAd9V6d5" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b><span id="xdx_868_z4xkLwYmS7Cf">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The preparation of condensed financial statements in conformity with GAAP requires management to make certain estimates, judgments, and assumptions that affect the reported amounts of assets and liabilities and disclosures as of the date of the condensed financial statements and the reported amounts of revenues and expenses during the reporting period. The Company bases its estimates on various factors, including historical experience, and on various other assumptions that are believed to be reasonable under the circumstances, when these carrying values are not readily available from other sources. Significant items subject to estimates and assumptions include useful lives of property and equipment, valuation of stock option, warrants and convertible notes measured at fair value, and impairment testing of intangible assets. Actual results may differ from these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5156606	usd
	us-gaap	Net Income Loss NetIncomeLoss	-10209149	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-48095304	usd
CY2024Q3	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0	usd
	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0	usd
CY2023Q3	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0	usd
	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0	usd
CY2024Q3	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2024Q3	AIMD	Excess Of Fdic Insured Limits ExcessOfFdicInsuredLimits	230115	usd
CY2023Q4	AIMD	Excess Of Fdic Insured Limits ExcessOfFdicInsuredLimits	1557487	usd
CY2024Q3	AIMD	Cash Cdic Insured Amount CashCDICInsuredAmount	3000000	twd
CY2024Q3	AIMD	Cash Cdic Insured Amount CashCDICInsuredAmount	94750	usd
CY2024Q3	AIMD	Excess Of Cdic Insured Limits ExcessOfCDICInsuredLimits	4557900	twd
CY2023Q4	AIMD	Excess Of Cdic Insured Limits ExcessOfCDICInsuredLimits	0	twd
CY2024Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	88765	usd
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	92708	usd
CY2024Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	1171	usd
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	1208	usd
CY2024Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	70765	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	73677	usd
CY2024Q3	us-gaap	Inventory Net InventoryNet	160701	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	167593	usd
CY2023Q3	AIMD	Inventory Writedowns Net Realizable Values InventoryWritedownsNetRealizableValues	63457	usd
	AIMD	Inventory Writedowns Net Realizable Values InventoryWritedownsNetRealizableValues	120931	usd
CY2024Q3	us-gaap	Notes Payable NotesPayable	12270000	usd
CY2023Q4	us-gaap	Notes Payable NotesPayable	5963556	usd
CY2024Q3	AIMD	Fair Value Change Of Senior Secured Convertible Note FairValueChangeOfSeniorSecuredConvertibleNote	-177212	usd
	AIMD	Fair Value Change Of Senior Secured Convertible Note FairValueChangeOfSeniorSecuredConvertibleNote	-275624	usd
	AIMD	Issurance Cost Of Senior Secured Convertible Note Measured At Fair Value IssuranceCostOfSeniorSecuredConvertibleNoteMeasuredAtFairValue	-308336	usd
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2024Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	13813434	shares
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	13813434	shares
CY2024Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1909810	shares
CY2023Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	894444	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures And Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations	0	shares
CY2023Q2	us-gaap	Employee Stock Ownership Plan Esop Shares In Esop EmployeeStockOwnershipPlanESOPSharesInESOP	871075	shares
CY2024Q3	us-gaap	Employee Stock Ownership Plan Esop Shares In Esop EmployeeStockOwnershipPlanESOPSharesInESOP	946432	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	7332	shares
CY2024Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	470791	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1318868	usd
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	324842	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	682833	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-3699317	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-2975846	usd
	us-gaap	Net Income Loss NetIncomeLoss	-10209149	usd
	us-gaap	Net Income Loss NetIncomeLoss	-7846048	usd
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11279220	shares
CY2024Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	11279220	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4058413	shares
CY2023Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	4058413	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7868997	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	7868997	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4026756	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	4026756	shares
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.33
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.33
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.73
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.73
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.30
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.30
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.95
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.95
CY2024Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5883727	shares
CY2023Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2983095	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5883727	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2983095	shares
CY2024Q3	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	389437	usd
CY2023Q4	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	87632	usd
CY2023Q3	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	12377	usd
	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	51721	usd
CY2024Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	110142	usd

Files In Submission

Name	View Source	Status
0001493152-24-043832-index-headers.html	Edgar Link	pending
0001493152-24-043832-index.html	Edgar Link	pending
0001493152-24-043832.txt	Edgar Link	pending
0001493152-24-043832-xbrl.zip	Edgar Link	pending
aimd-20240930.xsd	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
aimd-20240930_def.xml	Edgar Link	unprocessable
aimd-20240930_lab.xml	Edgar Link	unprocessable
aimd-20240930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
aimd-20240930_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AIMD
Ainos, Inc. Stock $aimd

2024 Q4 Form 10-Q Financial Statement

#000149315224043832 Filed on November 06, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AIMD Ainos, Inc. Stock $aimd

2024 Q4 Form 10-Q Financial Statement

#000149315224043832 Filed on November 06, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AIMD
Ainos, Inc. Stock $aimd